Skip to content
The Nexus
DossierENTITY

mRNA vaccine platform

Coverage of mRNA vaccine platform in the Nexus archive.

Earliest in view: Jun 1 · 20:58 UTCMost recent: Jun 1 · 20:58 UTC
Co-mentioned in this coverage
Coalition for Epidemic Preparedness Innovationsorganization1Modernaorganization1Stéphane Bancelperson1Bundibugyo ebolavirustopic1Democratic Republic of the Congoplace1
Recent coverage
  • HEALTHJun 1 · 20:58 UTCARS TECHNICA
    Moderna gets $50 million to develop mRNA Ebola vaccine against Bundibugyo

    CEPI has committed $50 million to Moderna for preclinical development and Phase 1 testing of an mRNA-based vaccine against Bundibugyo ebolavirus (BDBV). The funding aims to accelerate efforts to address an outbreak in the Democratic Republic of the Congo, leveraging Moderna's mRNA platform used during the COVID-19 pandemic.